Urge your members of Congress to support continued medical research funding
ASH provides the following resources to keep physicians informed of newly approved therapies, safety and prescription matters, and shortages of critical hematologic drugs.
Information about hematologic risk evaluation and mitigation strategies(REMs)
Resources to help clinicians and patients access high-cost hematologic drugs
Information and resources regarding shortages of drugs used to treat patients with hematologic diseases
Information about newly approved therapies and other important actions (e.g., updated safety information, new prescribing information) for patients provided in collaboration with the Food and Drug Administration (FDA)
Blood: How I Treat Hematology 2017 ASH Academy ASH On Demand
Get a synopsis of the top research presented at the latest ASH annual meeting.
Instantly access webcasts from ASH's many educational meetings and webinars.
Increase awareness, knowledge, and confidence regarding the role of biosimilars in clinical care with a free online course. CME/MOC available.
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
by American Society of Hematology